Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

This study has been completed.

Study NCT00086099 Information provided by MedImmune LLC

First Received: June 23, 2004 Last Updated: January 28, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2006
Primary Completion Date:	December 2005 (Final data collection date for primary outcome measure)